Deciphera Pharmaceuticals $135.1 million common stock offering
The common stock is listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
New Horizon Health HK$781.7 million top-up placement of shares
We advised New Horizon Health on the top-up placement
Jinxin Fertility Group HK$1.17 billion top-up placement of shares
The shares are listed on the Hong Kong Stock Exchange
Novavax $175.25 million convertible senior notes offering
The 5% convertible notes are due 2027
Terns Pharmaceuticals $86 million stock offering
The stock is listed on the Nasdaq Global Select Market
Coherus BioSciences $150 million at-the-market offering
The stock is listed on the Nasdaq Global Market
Priveterra Acquisition initial business combination with AEON Biopharma
We are advising Priveterra on the transaction
Illumina $1 billion notes offering
The investment-grade notes are due 2027
Prometheus Biosciences $500 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Amgen $28.5 billion Horizon Therapeutics acquisition financing
We advised the lender parties on the financing